医薬品分析試験アウトソーシング市場：サービス、試験手法、最終用途別-2024-2030年の世界予測

医薬品分析試験アウトソーシング市場規模は2023年に92億3,000万米ドルと推計され、2024年には100億7,000万米ドルに達し、CAGR 9.38%で2030年には173億米ドルに達すると予測されています。

医薬品分析試験アウトソーシングとは、製薬会社向けに様々な分析試験手順を専門に行う外部組織が提供する専門的サービスのことです。このようなアウトソーシングは、製薬企業がコスト効率を高め、専門知識を活用し、社内にない高度な技術の恩恵を受けるために採用する戦略的アプローチです。医薬品分析試験アウトソーシングの需要は、正確な医薬品バリデーションに対する規制当局の要求の高まり、高度な分析法を必要とする医薬品の複雑化、コアコンピタンスに集中したい製薬企業のコスト最適化努力などの要因によって牽引されています。成長が見込まれるとはいえ、知的財産権に関する懸念や、厳しい規制基準への準拠の必要性は、リードタイムとコストの増加につながりかねず、市場成長の抑制要因となっています。しかし、AIやハイスループット・スクリーニング法などの技術の進歩は、市場成長の新たな道筋を示しています。また、個別化医療や希少疾病用医薬品への動向は、専門的な分析検査サービスの可能性を広げ、医薬品分析試験アウトソーシング市場に大きなビジネスチャンスをもたらしています。

サービス医薬品の有効性と安全性を判定するバイオ分析試験サービスの需要

バイオ分析試験サービスは、臨床と非臨床の両方で不可欠です。臨床バイオ分析試験は、医薬品開発プロセスにおける重要な段階であり、生体液中の薬物の定量測定を伴う。この評価は、臨床試験における医薬化合物の有効性と安全性を決定するために最も重要です。非臨床生物分析試験は、医薬品開発サイクルの初期段階に不可欠な要素です。これは、ヒトに投与される前に物質の安全性と生物学的活性の予備的評価を確立するために、動物モデルを用いてin vivoまたはin vitroで新薬の実体を調べることを含みます。

医薬品分析試験の領域では、分析法の開発とバリデーションは、結果の正確性と信頼性を保証する重要な要素です。抽出性および溶出性のメソッドのカスタム開発と厳密なバリデーションは、医薬品とその包装材との適合性を評価するために不可欠です。同様に、不純物メソッドの開発は、製品の安全性と有効性に影響を及ぼす可能性のある不純物を特定し、定量するために極めて重要です。これと並行して、技術コンサルティングは、複雑な規制要件をナビゲートし、確実な結果を得るために分析手順を最適化するための専門家ガイダンスを提供します。

安定性試験は、医薬品の品質管理に不可欠な要素であり、医薬品の保存期間に関する知見を提供し、意図された保存期間を通じて安全性と有効性を維持することを保証します。加速安定性試験は、製品の寿命を予測するために長期的な環境影響をシミュレートする一方、原薬に関する試験では、さまざまな条件下での挙動を評価します。光安定性試験は、光への曝露が医薬品の安定性にどのような影響を与えるかを評価し、光に曝露された医薬品が許容できない程度まで分解しないことを確認します。安定性を示す方法のバリデーションは、医薬品の力価および純度の変化を検出するための分析手順の適合性を確認する徹底的な分析プロセスです。このバリデーションでは、特定の分析法が、分解によって生じる可能性のある原薬および製剤の変化を正確かつ確実に測定できることを確認します。

検査技術：サンプル中の分析対象物を効率的に分離・定量するクロマトグラフィーのメリット

クロマトグラフィーは、混合物の成分を定量・同定し、医薬品化合物を精製するために、製薬業界で広く使用されている汎用性の高い分離技術です。高い精度、複雑な混合物を分離する能力、分析用途から分取用途への拡張性から好まれています。質量分析法は、質量電荷比によって化合物を同定する分析技術です。この技術は、構造解明、微量成分の同定、不純物のプロファイリングに不可欠です。その高い特異性と感度は、薬物動態学、代謝研究、プロテオミクスに適した手法です。分光法は、光と物質との相互作用に基づく様々な技術を包含します。製薬業界では、構造解析、化合物同定、濃度決定に使用されます。

最終用途製造委託先による広範な高難易度試験サービスへのニーズの高まり

バイオ医薬品・医薬品セグメントには、生物由来製品（バイオ医薬品）と化学合成医薬品（医薬品）の両方の医薬品の開発・製造に携わる企業が含まれます。これらの企業が必要とする分析試験サービスには、純度評価、安定性試験、生物分析試験、バッチリリース試験などが含まれます。製造受託機関（CMO）は、医薬品開発から医薬品製造に至る包括的な一連のサービスを提供するために、他の製薬企業に契約ベースでサービスを提供する企業です。これらの企業は一般的に、高価なラボのインフラに投資する必要なく、規制コンプライアンスを維持し、製品の品質を確保するために分析試験を外注しています。

地域別インサイト

南北アメリカの医薬品分析試験アウトソーシング市場は力強い成長を示しています。この成長は、製薬業界と定評あるアウトソーシング企業の存在によって強化されています。米国食品医薬品局（FDA）を筆頭とする厳しい規制状況や、コスト効率、イノベーション、市場投入までの時間短縮に対する需要の高まりが、アウトソーシング活動を後押ししています。EMEA地域では、欧州が依然として医薬品分析試験アウトソーシング市場に大きく貢献しています。同市場は、先進的なヘルスケアインフラ、医薬品研究開発への多額の投資、同地域で整備された規制の枠組みなどの恩恵を受けています。中東・アフリカ地域は、欧州に比べ規模は小さいもの、ヘルスケア分野への投資の増加や、コスト削減と地域の専門知識を活用するための医薬品アウトソーシングへの関心の高まりに後押しされ、緩やかな拡大を続けています。APAC市場は、中国やインドなどの新興国を背景に急速な成長を遂げています。これらの国々は、コスト競争力のある労働力、医薬品分析の専門性の高まり、国際的な品質基準への準拠の高まりにより、ホットスポットとなりつつあります。現地の製薬メーカーの拡大とヘルスケアインフラへの海外投資の増加は、この地域における医薬品分析試験アウトソーシングサービスの新たな機会を生み出し続けています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは医薬品分析試験アウトソーシング市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、医薬品分析試験アウトソーシング市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.医薬品分析試験アウトソーシング市場の市場規模および予測は？

2.医薬品分析試験アウトソーシング市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.医薬品分析試験アウトソーシング市場の技術動向と規制枠組みは？

4.医薬品分析試験アウトソーシング市場における主要ベンダーの市場シェアは？

5.医薬品分析試験アウトソーシング市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医薬品の発見と開発における研究開発の増加
    • 薬剤処方の複雑さと厳格な規制基準への準拠の必要性
    • コスト最適化戦略としての医薬品分析試験アウトソーシングの好感度が高まっています
  • 抑制要因
    • 分析機器の高コストと最新設備の維持
  • 機会
    • 薬物検査手順における新たな技術的進歩
    • 製薬業界への投資増加
  • 課題
    • 知的財産権に関する懸念
• 市場セグメンテーション分析
  • サービス：医薬品の有効性と安全性を判断するためのバイオ分析試験サービスの需要
  • 試験技術：サンプル中の分析対象物を分離し定量化する効率性によるクロマトグラフィーの大きな利点
  • 最終用途：契約製造組織による広範囲にわたる高度に複雑なテストサービスに対する需要の高まり
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 医薬品分析試験アウトソーシング市場：サービス別

• 生体分析試験
• 方法の開発と検証
• 安定性テスト

第7章 医薬品分析試験アウトソーシング市場テスト手法別

• クロマトグラフィー
• 質量分析
• 分光法

第8章 医薬品分析試験アウトソーシング市場：最終用途別

• バイオ医薬品および医薬品
• 契約製造組織

第9章 南北アメリカの医薬品分析試験アウトソーシング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の医薬品分析試験アウトソーシング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの医薬品分析試験アウトソーシング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • スターリング・アキュリス、新たな買収により医薬品および分析試験分野に進出
  • ユーロフィンは、日本におけるアステラス製薬とのアウトソーシング契約により、バイオ医薬品製品の試験拠点を拡大
• 戦略分析と提言

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH PROCESS
• FIGURE 2. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET DYNAMICS
• FIGURE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS & PHARMACEUTICALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS & PHARMACEUTICALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 54. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 55. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 56. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 57. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 58. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 59. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 60. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 61. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 62. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 63. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 64. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 65. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 66. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 67. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 68. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 69. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 70. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 71. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 72. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 73. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 74. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 75. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 76. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 77. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 78. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 79. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 80. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 81. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 82. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 83. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 84. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 85. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 86. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 87. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 88. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 89. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 90. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 91. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 92. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 93. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 94. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 95. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 96. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 97. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 98. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 99. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 100. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 101. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 102. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 103. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 104. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 105. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 106. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 107. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 108. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 109. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 110. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 111. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 112. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 113. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 114. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 115. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 116. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 117. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 118. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 119. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 120. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 121. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 122. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 123. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 124. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 125. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 126. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 127. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 128. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 129. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 130. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 131. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 132. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 133. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 134. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 136. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 137. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 138. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 139. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 140. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 141. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 142. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 143. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 144. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 145. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 146. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 147. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 148. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 149. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 150. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 151. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 152. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 153. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 154. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 155. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 156. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 157. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 158. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 159. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 160. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 161. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 162. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 163. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 164. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 165. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 166. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 167. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 168. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 169. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 170. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 171. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 172. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 173. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 174. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 175. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 176. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 177. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 178. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 179. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 180. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 181. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 182. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 183. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 184. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 185. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 186. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 187. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 188. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 189. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 190. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 191. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 192. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 193. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 194. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 195. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 196. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 197. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 198. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 199. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 200. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 201. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 202. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 203. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 204. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 205. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 206. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 207. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 208. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 209. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 210. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 211. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 212. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 213. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 214. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 215. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 216. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 217. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 218. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 219. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 220. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 221. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 222. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 223. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 224. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 225. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 226. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 227. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 228. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 229. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 230. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 231. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 232. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 233. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 234. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 235. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 236. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 237. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 238. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 239. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 240. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 241. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 242. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 243. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 244. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 247. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 248. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 249. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 250. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 251. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 252. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 253. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
• TABLE 254. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
• TABLE 255. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
• TABLE 256. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
• TABLE 257. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
• TABLE 258. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
• TABLE 259. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 260. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 261. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 262. TAIWAN PHARMACEUTICAL ANALYT

[195 Pages Report] The Pharmaceutical Analytical Testing Outsourcing Market size was estimated at USD 9.23 billion in 2023 and expected to reach USD 10.07 billion in 2024, at a CAGR 9.38% to reach USD 17.30 billion by 2030.

Pharmaceutical analytical testing outsourcing refers to the professional services provided by external organizations that specialize in performing various analytical testing procedures for pharmaceutical companies. This practice of outsourcing is a strategic approach adopted by pharmaceutical companies to attain cost efficiencies, access specialized expertise, and benefit from advanced technologies that they may not possess in-house. The demand for pharmaceutical analytical testing outsourcing is driven by factors such as increasing regulatory demands for precise drug validation, the rising complexity of drugs, which requires advanced analytical methods, and cost optimization efforts from pharmaceutical companies looking to focus on core competencies. Despite the growth prospects, intellectual property concerns and the need for compliance with stringent regulatory standards, which can lead to an increase in lead time and costs, act as a restraint for market growth. However, advancements in technology, such as AI and high-throughput screening methods, present new avenues for market growth. The trend towards personalized medicine and orphan drugs also opens up a potential for specialized analytical testing services, presenting significant opportunities for the pharmaceutical analytical testing outsourcing market.

Services: Demand for bioanalytical testing services to determine efficacy and safety of pharmaceutical products

Bioanalytical testing services are essential for both clinical and non-clinical settings. Clinical bioanalytical testing is a critical phase in the drug development process, entailing the quantitative measurement of drugs in biological fluids. This evaluation is paramount for determining the efficacy and safety of pharmaceutical compounds in clinical trials. Non-clinical bioanalytical testing is an essential early-stage component of the drug development cycle. This involves the examination of new drug entities in vivo or in vitro in animal models to establish a preliminary assessment of the safety and biological activity of a substance before it is administered to humans.

In the realm of pharmaceutical analytical testing, method development and validation are critical components that ensure accuracy and reliability in results. Custom development and rigorous validation of methods for extractable and leachable are vital for assessing the compatibility between drug products and their packaging. Similarly, the development of an impurity method is crucial for identifying and quantifying potential impurities that could affect product safety and efficacy. Alongside this, technical consulting provides expert guidance to navigate complex regulatory requirements and optimize analytical procedures for robust outcomes.

Stability testing represents an integral part of pharmaceutical quality control, offering insights into a drug's shelf life and ensuring it remains safe and effective throughout its intended storage period. Accelerated stability testing simulates long-term environmental effects to predict a product's lifespan, while tests on the drug substance evaluate its behavior under varied conditions. Photostability testing assesses how exposure to light affects the stability of pharmaceutical products to ensure drug products do not degrade to an unacceptable degree when exposed to light. Stability indicating method validation is a thorough analytical process that confirms the suitability of analytical procedures for detecting changes in a drug's potency and purity. It involves the validation of specific methods to ensure they can accurately and reliably measure changes in the drug substances and products, which could result from degradation.

Testing Technique: Significant benefits of chromatography owing to its efficiency in separating and quantifying analytes in samples

Chromatography is a versatile separation technique extensively used in the pharmaceutical industry for quantifying and identifying the components of a mixture and purifying pharmaceutical compounds. It is preferred for its high precision, ability to separate complex mixtures, and scalability from analytical to preparative applications. Mass spectrometry offers an analytical technique that identifies compounds by their mass-to-charge ratio. This technique is indispensable for structural elucidation, identification of trace components, and impurity profiling. Its high specificity and sensitivity make it a suitable method for pharmacokinetics, metabolism studies, and proteomics. Spectroscopy encompasses a range of techniques based on the interaction of light with matter. In the pharmaceutical industry, it is used for structural analysis, compound identification, and concentration determination.

End-use: Growing need for a broad range of high-complexity testing services from contract manufacturing organizations

The Biopharmaceuticals & pharmaceuticals segment encompasses companies involved in the development and manufacturing of drugs, both biologically derived products (biopharmaceuticals) and chemically synthesized drugs (pharmaceuticals). Analytical testing services required by these entities include purity assessment, stability testing, bioanalytical testing, and batch-release testing, among others. Contract manufacturing organizations (CMOs) are companies that serve other pharmaceutical businesses on a contract basis to provide a comprehensive suite of services ranging from drug development to drug manufacturing. These organizations commonly outsource analytical testing to maintain regulatory compliance and ensure product quality without needing to invest in expensive laboratory infrastructure.

Regional Insights

The pharmaceutical analytical testing outsourcing market in the Americas is demonstrating robust growth. This growth is fortified by the presence of a pharmaceutical industry, along with well-established outsourcing companies. The stringent regulatory landscape, spearheaded by the U.S. Food and Drug Administration (FDA), and the increasing demand for cost-efficiency, innovation, and faster time-to-market are driving outsourcing activities. Europe remains a major contributor to the pharmaceutical analytical testing outsourcing market within the EMEA region. The market is benefiting from advanced healthcare infrastructure, significant investment in pharmaceutical R&D, and well-defined regulatory frameworks in the region. The Middle East and Africa, while smaller in comparison to Europe, are experiencing gradual expansions fueled by growing investment in healthcare sectors and a rising interest in pharmaceutical outsourcing to reduce costs and leverage regional expertise. The APAC market is experiencing rapid growth in pharmaceutical analytical testing outsourcing, backed by emerging economies such as China and India. These countries are becoming hotspots owing to their cost-competitive labor, growing expertise in pharma analytics, and increasing compliance with international quality standards. The expansion of local pharmaceutical manufacturers, coupled with increased foreign investments in healthcare infrastructure, continues to create new opportunities for pharmaceutical analytical testing outsourcing services in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Analytical Testing Outsourcing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Analytical Testing Outsourcing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Analytical Testing Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Bio-Pharma, Alcami Corporation, AptarGroup, Inc., Ascendia Pharmaceuticals, BioAgilytix, Cambrex Corporation, Catalent, Inc, Charles River Laboratories International, Inc., Element Materials Technology, Eurofins Scientific SE, ICON PLC, Intertek Group PLC, Laboratory Corporation of America Holdings, LGM Pharma, Medpace Holdings, Inc., Merck KGaA, Pace Analytical Services, Inc., SGS SA, Societal CDMO, Source BioScience, Syneos Health, Thermo Fisher Scientific Inc., West Pharmaceutical Services, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Analytical Testing Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Services
  • Bioanalytical Testing
    • Clinical
    • Non-Clinical

• Method Development & Validation
  • Extractable & Leachable
  • Impurity Method
  • Technical Consulting

• Stability Testing
  • Accelerated Stability Testing
  • Drug Substance
  • Photostability Testing
  • Stability Indicating Method Validation
• Testing Technique
  • Chromatography
  • Mass Spectrometry
  • Spectroscopy

• End-use
  • Biopharmaceuticals & Pharmaceuticals
  • Contract Manufacturing Organizations

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Pharmaceutical Analytical Testing Outsourcing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Analytical Testing Outsourcing Market?

3. What are the technology trends and regulatory frameworks in the Pharmaceutical Analytical Testing Outsourcing Market?

4. What is the market share of the leading vendors in the Pharmaceutical Analytical Testing Outsourcing Market?

5. Which modes and strategic moves are suitable for entering the Pharmaceutical Analytical Testing Outsourcing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing research and development in drug discovery and development
    • 5.1.1.2. Complexity of drug formulations and need for compliance with stringent regulatory standards
    • 5.1.1.3. Growing preferences for pharmaceutical analytical testing outsourcing as a cost optimization strategy
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of analytical instruments and maintaining state-of-the-art facilities
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging technological advancements in drug testing procedures
    • 5.1.3.2. Increasing investments in the pharmaceutical industry
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with intellectual property rights
• 5.2. Market Segmentation Analysis
  • 5.2.1. Services: Demand for bioanalytical testing services to determine efficacy and safety of pharmaceutical products
  • 5.2.2. Testing Technique: Significant benefits of chromatography owing to its efficiency in separating and quantifying analytes in samples
  • 5.2.3. End-use: Growing need for a broad range of high-complexity testing services from contract manufacturing organizations
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Pharmaceutical Analytical Testing Outsourcing Market, by Services

• 6.1. Introduction
• 6.2. Bioanalytical Testing
• 6.3. Method Development & Validation
• 6.4. Stability Testing

7. Pharmaceutical Analytical Testing Outsourcing Market, by Testing Technique

• 7.1. Introduction
• 7.2. Chromatography
• 7.3. Mass Spectrometry
• 7.4. Spectroscopy

8. Pharmaceutical Analytical Testing Outsourcing Market, by End-use

• 8.1. Introduction
• 8.2. Biopharmaceuticals & Pharmaceuticals
• 8.3. Contract Manufacturing Organizations

9. Americas Pharmaceutical Analytical Testing Outsourcing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Sterling Accuris expands into pharmaceutical and analytical testing through new acquisition
  • 12.3.2. Eurofins expands its biopharmaceutical products testing footprint with an outsourcing agreement with Astellas in Japan
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio